QSS
ANIP icon

Quantitative Systematic Strategies’s ANI Pharmaceuticals ANIP Stock Holding History

Quantitative Systematic Strategies’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,887
Closed -$276K – 687
2018
Q3 		$276K Buy
+4,887
New +$299K 0.05% 438

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Quantitative Systematic Strategies's ANIP Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of ANI Pharmaceuticals (ANIP) in Q4 2018, closing a stake of 4,887 shares — an estimated $276K sold.

Quantitative Systematic Strategies first reported a position in ANIP in Q3 2018 and held it in 1 quarter. The position peaked at $276K in Q3 2018. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining ANI Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 4,887 ANI Pharmaceuticals shares in Q4 2018, an estimated $276K.
  • Quantitative Systematic Strategies first reported a position in ANI Pharmaceuticals in Q3 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's ANI Pharmaceuticals position peaked at $276K in Q3 2018.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.